In this episode, Dr. Todd Cohen kicks off prostate cancer awareness month by interviewing prostate cancer survivor - Byron Sparkman. Byron shares his personal cancer journey starting at the time he learned of his elevated PSA, to getting a biopsy, and the additional steps he took to feel comfortable making a treatment decision. Byron also shares his advice for men and families that are currently going through similar experiences and how they to can make more informed healthcare decisions. Send u...
Sep 02, 2020•25 min
Dr. Paul Sieber continues his conversation with Dr. Todd Cohen around managing the advanced prostate cancer patient. The use of somatic and germline testing to support decision making within the treatment algorithm are discussed. Medical management changes of positive mutation carriers and the commercial use of PARP inhibitors are also explored. Send us a text
Aug 26, 2020•24 min
In this episode, Dr. Paul Sieber from Lancaster Urology sits down to talk about how his practice is managing advanced prostate cancer. The rise in the number of M0 prostate cancer patients and how advanced treatment protocols are being used to provide better care are discussed at length. Send us a text
Aug 18, 2020•31 min•Season 2Ep. 11
Dr. Walter Rayford joins Dr. Todd Cohen to talk about the racial disparities among African American men and prostate cancer. Dr. Rayford has been extensively involved in researching discrepancies in prostate cancer disease outcomes and shares his experiences and recommendations for better educating and treating the African American patient. Dr. Rayford also talks about his work with advocacy groups and what these groups are doing to better educate and support men with prostate cancer. Send us a ...
Aug 10, 2020•28 min•Season 2Ep. 11
Dr. Cohen and Dr. Neal Shore continue their conversation about prioritizing patient care using personalized testing to better risk stratify and create customized treatment plans. Send us a text
May 14, 2020•20 min•Season 2Ep. 10
In this episode, Dr. Neal Shore, with Atlantic Urology Clinics in Myrtle Beach, South Carolina, and Medical Director at Carolina Urologic Research Center discusses how his practice continues to adapt to the current COVID-19 pandemic, specifically around the importance of patient prioritization during their recovery phase. Strategies to better decide which patients should be biopsied right away and how to prioritize treatment is discussed in detail. Dr. Shore and Dr. Todd Cohen will talk about th...
May 14, 2020•19 min•Season 2Ep. 9
Dr. Cohen continues his conversation with Urologists and CEOs Dr. Ed Cohen and Dr. David Ellis on how their respective practices continue to adapt to the current crisis. The topics of federal loan programs, personal protective equipment (PPE) and the processes behind successfully executing tele-health are discussed. Send us a text
Apr 20, 2020•31 min•Season 2Ep. 8
In this episode of the COVID-19 series, Dr. David Ellis and Dr. Ed Cohen continue to share how they have further adapted their individual operations and practices to deal with the current pandemic. Both CEOs share at-length their short and long-term concerns and how they plan to manage patients once social distancing guidelines are rescinded. Send us a text
Apr 09, 2020•28 min•Season 2Ep. 7
In this episode, Dr. Todd Cohen follows up on his previous conversation with Dr. David Ellis, and Dr. Ed Cohen on how these providers and their practices continue to adapt and evolve patient care amid the COVID-19 pandemic. The challenges associated with implementing tele-health workflows to maintain existing patient volume is discussed at length. The future role of tele-health and what that means for Urologists going forward is also explored. Send us a text...
Mar 30, 2020•28 min•Season 2Ep. 6
Wayne Sotile, PhD, founder of the Sotile Center for Resilience and the Center for Physician Resilience shares some powerful ideas on how physicians and other healthcare providers can manage individual burnout. Drawing on this extensive experience, Dr. Sotile shares how physicians can become more resilient, even thrive in times of increased stress. Send us a text
Mar 30, 2020•32 min•Season 2Ep. 5
Dr. Cohen sits down with Dr. David Ellis from MidLantic Urology and Dr. Edward Cohen, from Genesis Healthcare to talk about the challenges of managing their day-to-day operations amid the COVID-19 pandemic. The use of digital technology, like tele-medicine is being implemented to ensure that routine urological care continues while keeping patients safe through social distancing. Send us a text...
Mar 18, 2020•14 min•Season 2Ep. 4
In this episode, Dr. Matthew Cooperberg, Urologist and Professor of Urology; Epidemiology & Biostatistics at UCSF talks about the parallels between breast and prostate cancer and how precision medicine in Urology is continuously evolving. The role of family history, mutation status, and the impact it is having on current and future prostate cancer treatment is explored. Send us a text
Feb 28, 2020•32 min•Season 2Ep. 2
Dr. Brian Richardson, Urologist and men's health activist talks about his experience dealing with prostate cancer in his own family and how it influenced him to pursue a career in Urology. Dr. Richardson also shares his passion for men's health advocacy and how it led him to create the first fun run in Montgomery, Alabama geared towards education and awareness around men's health. Send us a text...
Feb 05, 2020•22 min•Season 2Ep. 3
In this episode, The Modern Urologist sits down with Dr. Angelo Baccala, Division Chief of Urology at Lehigh Valley Hospital Network to talk about his motivation for pursuing an MBA and the benefits it provides. The idea of protocols and pathways are discussed as a means to combat variation in patient care, while improving upon workflow efficiency. Dr. Baccala discusses his thoughts on the future of value-based care vs fee for service reimbursement models. Send us a text...
Nov 18, 2019•21 min•Season 1Ep. 9
Dr. Aaron Berger and Nurse Navigator, Kristyn Minetti join the show to discuss their experience building out and growing an advanced prostate cancer clinic. Genetic testing to personalize prostate cancer treatment, the challenges associated with family history and implications of genetic test results are discussed at length. Send us a text
Nov 18, 2019•22 min•Season 2Ep. 1
Dr. Mike Gambla from Central Ohio Urology Group joins The Modern Urologist to talk about his experience with private equity acquisitions (PE) in the Urology space. The idea of potential culture disruptions and other pros and cons of PE acquisitions are discussed at length. Dr. Gambla offers his own insights to any independent practice considering an acquisition. The conversation changes to the role nurse navigators play in getting patients with advanced disease states better care through second ...
Nov 18, 2019•23 min•Season 1Ep. 10
In this episode, The Modern Urologist sits down at LUGPA with Dr. Jason Haffron, from Michigan Institute of Urology to talk about how his patient first mentality inspired him to develop new treatment pathways. The topic of being a young practicing urologist and how to become an influence within a well-established group practice are discussed. Treatment sequencing for advanced prostate disease is debated and how advances in treatment paradigms are leading to significant improvements in quality of...
Nov 15, 2019•23 min•Season 1Ep. 7
In this episode, The Modern Urologist sits down with Dr. David Morris, from Urology Associates P.C. in Tennessee to talk about the history of MRI and the impact it can have on biopsy and surgical planning. Dr. Morris further discusses societal MRI guidelines, the utilization in mainstream urology and how he personally uses this technology in his treatment of prostate cancer. The limitations of using MRI to risk stratify patients is discussed The conversation then turns to compliance tracking and...
Nov 15, 2019•18 min•Season 1Ep. 7
In this episode, The Modern Urologist sits down with E.Scot Davis, CEO of Arkansas Urology to talk about his experience creating men's health clinics and advance pathways to improve the competitive advantage of his organization. The conversation then dives into Scot's vast experience managing large group physician practices and how he developed a unique; patient-centric culture within his organization. Send us a text...
Nov 15, 2019•37 min•Season 1Ep. 8
In this episode, Dr. Cohen sits down at AACU with Dr Benjamin Lowentritt, Director of the Prostate Cancer Care Program at Chesapeake Urology to talk about his experience setting up advanced prostate cancer clinics. Dr. Lowentritt also talks at length about the collaborative model he and his partners are using to develop processes for delivering new levels of patient care. New treatments and advanced therapies for the treatment of metastatic disease are discussed at length and how the use of gene...
Oct 23, 2019•26 min•Season 1Ep. 6
In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and shares a compelling story about how genetic testing for BRCA status allowed him to get a compassionate writ for the PARP inhibitor - Lymparza which drama...
Oct 22, 2019•21 min•Season 1Ep. 4
In this episode, Dr. Cohen sits down with Sarah Nielsen, Genetic Counselor to talk about her experience educating and developing screening protocols for providers who are new to the genetics space. The implications of genetic mutations,family history and the limitations of access to genetic counselors are also discussed and how collaborative solutions are being employed to move this important testing forward in the Urology space. Send us a text...
Oct 18, 2019•20 min•Season 1Ep. 3
In this episode, Dr. Cohen sits down with Dr. Mark Edney, Medical Director at Peninsula Institute for Laparoscopic and Robotic Surgery to discuss the limitations of relying on clinical pathology alone and how the addition of Prolaris allows providers to truly understand how a patient's tumor is behaving on a biological level. Dr, Edney also talks about his personal use of biomarkers in his practice and why he believes there is a slow adoption rate of molecular tests in the Urology space. Fa...
Oct 17, 2019•22 min•Season 1Ep. 2
Dr. Todd Cohen, Medical Director of Urology at Myriad Genetics discusses his intentions for creating this casual, yet educational podcast about modern topics in Urology. Enjoy! Send us a text
Oct 16, 2019•54 sec•Season 1Ep. 1
